Difficulty: Medium
Average Score: 74%
Practice
A 64-year-old man is discharged from the intensive care unit to home after suffering a myocardial infarction. He has a history of atrial arrhythmias. Which of the following agents would be best for this patient to prevent recurrence of arrhythmia and decrease his risk of mortality?
Correct answer
B
Rationale
In this scenario, the most appropriate choice for the patient to prevent recurrence of arrhythmia and decrease mortality risk is option B) Sotalol. Sotalol is a non-selective beta-blocker with Class III antiarrhythmic properties. It helps in controlling atrial arrhythmias by prolonging repolarization and refractoriness of the cardiac muscle, thus preventing abnormal electrical activity. This action makes it effective in managing atrial fibrillation and flutter, which are common arrhythmias associated with myocardial infarction.
Now, let's analyze why the other options are incorrect:
A) Imipramine: Imipramine is a tricyclic antidepressant that is not indicated for managing arrhythmias. It does not possess antiarrhythmic properties and would not be effective in this case.
C) Procainamide: Procainamide is a Class Ia antiarrhythmic drug that is not commonly used for atrial arrhythmias. It is more indicated for ventricular arrhythmias and has a different mechanism of action compared to Sotalol.
D) Propafenone: Propafenone is a Class Ic antiarrhythmic drug that is also more commonly used for ventricular arrhythmias. It is not the first-line choice for managing atrial arrhythmias post-myocardial infarction.
Educational Context:
Understanding the mechanisms of action and appropriate use of different classes of antiarrhythmic drugs is crucial in nursing pharmacology. It is essential for nurses to be able to select the most appropriate medication based on the patient's clinical presentation, history, and desired outcomes. In this case, selecting Sotalol for a patient with a history of atrial arrhythmias post-myocardial infarction highlights the importance of tailoring pharmacological interventions to individual patient needs to optimize outcomes and reduce risks.
Now, let's analyze why the other options are incorrect:
A) Imipramine: Imipramine is a tricyclic antidepressant that is not indicated for managing arrhythmias. It does not possess antiarrhythmic properties and would not be effective in this case.
C) Procainamide: Procainamide is a Class Ia antiarrhythmic drug that is not commonly used for atrial arrhythmias. It is more indicated for ventricular arrhythmias and has a different mechanism of action compared to Sotalol.
D) Propafenone: Propafenone is a Class Ic antiarrhythmic drug that is also more commonly used for ventricular arrhythmias. It is not the first-line choice for managing atrial arrhythmias post-myocardial infarction.
Educational Context:
Understanding the mechanisms of action and appropriate use of different classes of antiarrhythmic drugs is crucial in nursing pharmacology. It is essential for nurses to be able to select the most appropriate medication based on the patient's clinical presentation, history, and desired outcomes. In this case, selecting Sotalol for a patient with a history of atrial arrhythmias post-myocardial infarction highlights the importance of tailoring pharmacological interventions to individual patient needs to optimize outcomes and reduce risks.